23:38 , Jun 11, 2019 |  BC Extra  |  Politics & Policy

New China regulations on genetic resources underscore flash point in U.S.-China tensions

Access to genomic data is becoming a flash point in geopolitical tensions between the U.S. and China as both sides are putting in place measures to restrict and scrutinize access to the data. As a...
00:33 , Jun 11, 2019 |  BC Extra  |  Politics & Policy

Senators call for HHS probe into CMS genetic testing payments to Chinese-linked companies

Sens. Charles Grassley (R-Iowa) and Marco Rubio (R-Fla.) have asked the HHS inspector general to investigate payments made by CMS to U.S. genetic testing companies that are partnered with companies that have ties to Beijing....
21:02 , Jun 6, 2019 |  BC Innovations  |  Emerging Company Profile

Scipher: decoding drug response from protein interactions

To improve the accuracy of therapeutic response predictions, Scipher has incorporated protein-protein interaction maps into its machine learning-based analyses of patient gene expression data to spotlight pathologically relevant markers. According to Scipher Medicine Corp. CEO...
17:46 , Feb 8, 2019 |  BC Week In Review  |  Financial News

DNAnexus raises $68M to advance its bioinformatics platform

DNAnexus Inc. (Mountain View, Calif.) raised $68 million in a financing that will enable the bioinformatics company to advance its DNAnexus Apollo platform. DNAnexus launched the cloud-based platform in October. It provides users access to...
18:32 , Feb 6, 2019 |  BC Extra  |  Financial News

DNAnexus raises $68M to advance its bioinformatics platform

DNAnexus Inc. (Mountain View, Calif.) raised $68 million in a financing that will enable the bioinformatics company to advance its DNAnexus Apollo platform. DNAnexus launched the cloud-based platform in October. It provides users access to...
19:41 , Dec 14, 2018 |  BC Week In Review  |  Financial News

WuXi AppTec unchanged in first day of trading on Hong Kong exchange

Shares of WuXi AppTec Co. Ltd. (Shanghai:603259; HKSE:2359) were unchanged in the first day of trading in Hong Kong Dec. 13, closing at HK$68. WuXi AppTec priced the offering at HK$68, near the middle of...
22:02 , Dec 7, 2018 |  BC Extra  |  Financial News

WuXi AppTec prices Hong Kong offering in stormy market

Despite global trade headwinds and a choppy market for biopharma stocks in China, WuXi AppTec Co. Ltd. (Shanghai:603259; HKSE:2359) managed to price its Hong Kong listing within its proposed range Friday, potentially raising HK$7.9 billion...
18:27 , Nov 30, 2018 |  BC Week In Review  |  Company News

WuXi NextCode investing in genomic sequencing project in Ireland

WuXi NextCode Genomics Inc. (Cambridge, Mass.) unveiled plans to expand an Irish sequencing program by investing up to $400 million in its partner Genomics Medicine Ireland Ltd. (Dublin, Ireland), which it acquired in November. The...
23:49 , Nov 27, 2018 |  BC Extra  |  Company News

WuXi NextCode investing in genomic sequencing project in Ireland

WuXi NextCode Genomics Inc. (Cambridge, Mass.) unveiled plans to expand an Irish sequencing program by investing up to $400 million in its recently acquired partner, Genomics Medicine Ireland Ltd. (Dublin, Ireland). The investment aims to...
22:14 , Oct 11, 2018 |  BC Innovations  |  Strategy

Border security for China’s genomes

China’s policies on sharing genomic data have so far produced cumbersome but manageable hurdles for cross-border clinical trials and translational research. But the explosive growth of its genomics industry, and the backdrop of rising political...